Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/26409
Title: | Endovascular clot retrieval for M2 segment middle cerebral artery occlusion: a systematic review and meta-analysis. | Austin Authors: | Findakly, Salam;Maingard, Julian;Phan, Kevin;Barras, Christen D;Jhamb, Ashu;Chandra, Ronil;Thijs, Vincent N ;Brooks, Mark;Asadi, Hamed | Affiliation: | School of Medicine, Deakin University, Geelong, Victoria, Australia The University of Adelaide, Adelaide, South Australia, Australia Stroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, Victoria, Australia Monash Health, Melbourne, Victoria, Australia NeuroSpine Surgery Research Group, Prince of Wales Private Hospital, Sydney, New South Wales, Australia Interventional Neuroradiology Unit, Monash Imaging, Monash Health, Melbourne, Victoria, Australia Radiology South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia Department of Imaging, Monash University, Melbourne, Victoria, Australia Neurology The University of Melbourne, Melbourne, Victoria, Australia |
Issue Date: | May-2020 | Publication information: | Internal Medicine Journal 2020; 50(5): 530-541 | Abstract: | Endovascular clot retrieval (ECR) is the standard of care for acute ischaemic stroke due to large vessel occlusion. However, isolated occlusion of the M2 segment of the middle cerebral artery (MCA) was underrepresented in the landmark trials. Given the potential treatment benefit associated with M2 MCA occlusions, we aimed to evaluate the outcome of patients undergoing ECR for M2 occlusion. We conducted a systematic review and meta-analysis of the available literature that included patients with M2 MCA occlusions who underwent ECR. Successful reperfusion was defined as a treatment in cerebral ischaemia score of 2b-3. Good outcome was defined as a modified Rankin Scale score ≤ 2. We also analysed complications such as post-procedure symptomatic intracranial haemorrhage and mortality at 3 months. Fifteen studies including 1105 patients with isolated M2 occlusions were analysed. Successful reperfusion occurred in 75.4% (95% confidence interval (CI) 67.7-84.1%) of patients; good outcome was observed in 58.3% (95% CI 51.7-63.8% of patients. The rate of symptomatic intracranial haemorrhage was 5.1% (95% CI 4.2-8.3%), and 3-month mortality rate was 12.2% (95% CI 10.4-16.3%). The outcomes of ECR treatment of M2 occlusions are favourable, with good safety profile. Comparison to medical management from large registries or randomised controlled trials is warranted. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/26409 | DOI: | 10.1111/imj.14333 | ORCID: | 0000-0002-1177-2052 0000-0001-8958-2411 |
Journal: | Internal Medicine Journal | PubMed URL: | 31059208 | Type: | Journal Article | Subjects: | M2 endovascular clot retrieval ischaemic Stroke |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.